In 2013, Rodríguez-Rodríguez et al. evaluated whether a combined GRS, including APOE, BIN1, PICALM, and CLU, is associated with either risk of conversion or with rapid progression from MCI to AD (114). Here, CLU is linked to Alzheimer disease.